Media officers for the U.S. Department of Health and Human Services have promised to make top HHS officials available to answer reporters’ questions, after AHCJ President Ivan Oransky, M.D., called for a press conference with the HHS secretary and the administrator of the Center for Medicare & Medicaid Services.
“We’re looking at ways to make our officials more available in multiple settings,” said Mark Weber, deputy assistant secretary for public affairs for human services. “It might not be a press conference but a series of venues.”
Imagine you’re researching a story about a new medical device undergoing federal review. You send an email to a source seeking details. But unbeknownst to you, your email has been infected with malware. When your message is opened, the software secretly scours your source’s computer for insider information.
It’s a hypothetical situation – but not far-fetched, says Geoffrey King, a lawyer and lecturer who previously ran the Internet and technology policy program at the Committee to Protect Journalists. Continue reading →
The Food and Drug Administration has banned a communications practice that troubled journalists and sparked protests from AHCJ and others.
The agency has forbidden its media staff from using “close-hold embargoes,” in which reporters receive early access to information provided they promise not to seek comments from others until the embargo lifts, according to a letter sent Thursday to Karl Stark, president of the Association of Health Care Journalists. Continue reading →
AHCJ is protesting the Food and Drug Administration’s recent restrictive practices in handling news embargoes and has asked the agency for clarification of its policies.
In an Oct. 11 letter to Jason Young, the FDA’s acting assistant commissioner for media affairs, AHCJ President Karl Stark raised strong objections to the practice of providing embargoed information on the condition that reporters refrain from seeking outside comment until the embargo lifts. Continue reading →